HR 7251 · 115th Congress · Health

Hatch-Waxman Integrity Act of 2018

Introduced 2018-12-11· Sponsored by Rep. Flores, Bill [R-TX-17]· House

Bill Progress

✓
Introduced
2
Committee
3
House Vote
4
Senate
5
Enacted
Latest: Referred to the Committee on Energy and Commerce, and in addition to the Committee on Financial Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.(2018-12-11)

Plain Language Summary

[AI summary unavailable — showing source text] Hatch-Waxman Integrity Act of 2018 This bill amends the Federal Food, Drug, and Cosmetic Act and the Securities Exchange Act of 1934 to prevent a generic drug or biosimilar manufacturer from using a specific review process for challenging pharmaceutical drug or biologic patents.…

Summarized by Claude AI · Non-partisan · For informational purposes only